Evaluation of risk factors for cytomegalovirus DNAemia after end of regular prophylaxis after heart transplantation

Evaluation of risk factors for cytomegalovirus DNAemia after end of regular prophylaxis after heart transplantation

Abstract Background Cytomegalovirus (CMV) infections after heart transplantation (HTx) can cause cardiac allograft vasculopathy. Consequently, monitoring and prophylaxis for cytomegalovirus deoxyribonucleic acid (CMV‐DNAemia) within the first weeks after HTx is recommended. Methods All patients who...

Full description

Bibliographic Details
Main Authors: Moritz Benjamin Immohr, Daniel Oehler, Freya Sophie Jenkins, Nikolas Kalampokas, Vincent Hendrik Hettlich, Dennis Sigetti, Fabian Voß, Hannan Dalyanoglu, Hug Aubin, Payam Akhyari, Artur Lichtenberg, Udo Boeken
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:Immunity, Inflammation and Disease
Subjects:
cardiac allograft vasculopathy
cytomegalovirus
heart transplantation
prophylaxis
Online Access:https://doi.org/10.1002/iid3.1075

Internet

https://doi.org/10.1002/iid3.1075

Similar Items